Precigen Stock Performance
| PGEN Stock | USD 4.55 0.37 8.85% |
On a scale of 0 to 100, Precigen holds a performance score of 10. The company holds a Beta of 0.85, which implies possible diversification benefits within a given portfolio. Precigen returns are very sensitive to returns on the market. As the market goes up or down, Precigen is expected to follow. Please check Precigen's potential upside, and the relationship between the total risk alpha and kurtosis , to make a quick decision on whether Precigen's historical price patterns will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Precigen are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting technical and fundamental indicators, Precigen displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 8.85 | Five Day Return 8.59 | Year To Date Return 6.31 | Ten Year Return (83.06) | All Time Return (80.73) |
1 | Precigen Inc Q3 2025 Earnings Call Highlights FDA Approval and U.S. ... | 11/14/2025 |
2 | Will Precigen Inc. stock benefit from commodity prices - July 2025 Recap Long-Term Safe Investment Ideas - newser.com | 11/18/2025 |
3 | Disposition of 937308 shares by Kirk Randal J of Precigen at 3.83 subject to Rule 16b-3 | 11/21/2025 |
4 | Precigen Is Still A Buy After The Papzimeos Rally - Seeking Alpha | 11/25/2025 |
5 | Disposition of 1079137 shares by Helen Sabzevari of Precigen subject to Rule 16b-3 | 12/02/2025 |
6 | Disposition of 235467 shares by Kindler Jeffrey B of Precigen at 3.6349 subject to Rule 16b-3 | 12/12/2025 |
7 | Spotlighting Bridgewater Bancshares And 2 Other Growth Stocks With Strong Insider Ownership - simplywall.st | 12/16/2025 |
8 | Disposition of 9931 shares by Kirk Randal J of Precigen at 4.18 subject to Rule 16b-3 | 12/22/2025 |
9 | Precigen Advances Genetic Medicine Platforms | 12/29/2025 |
10 | Precigen Shares Down 6.1 percent Heres What Happened | 01/05/2026 |
| Begin Period Cash Flow | 7.8 M | |
| Total Cashflows From Investing Activities | -20.7 M |
Precigen Relative Risk vs. Return Landscape
If you would invest 319.00 in Precigen on October 9, 2025 and sell it today you would earn a total of 136.00 from holding Precigen or generate 42.63% return on investment over 90 days. Precigen is currently generating 0.7291% in daily expected returns and assumes 5.5743% risk (volatility on return distribution) over the 90 days horizon. In different words, 50% of stocks are less volatile than Precigen, and 86% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Precigen Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Precigen's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Precigen, and traders can use it to determine the average amount a Precigen's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1308
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PGEN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Precigen is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Precigen by adding it to a well-diversified portfolio.
Precigen Fundamentals Growth
Precigen Stock prices reflect investors' perceptions of the future prospects and financial health of Precigen, and Precigen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Precigen Stock performance.
| Return On Equity | -6.68 | ||||
| Return On Asset | -0.67 | ||||
| Operating Margin | (32.54) % | ||||
| Current Valuation | 1.45 B | ||||
| Shares Outstanding | 352.91 M | ||||
| Price To Earning | (2.06) X | ||||
| Price To Book | 35.28 X | ||||
| Price To Sales | 255.18 X | ||||
| Revenue | 3.92 M | ||||
| Gross Profit | (52.67 M) | ||||
| EBITDA | (123.5 M) | ||||
| Net Income | (126.23 M) | ||||
| Cash And Equivalents | 115.3 M | ||||
| Cash Per Share | 0.55 X | ||||
| Total Debt | 5.5 M | ||||
| Debt To Equity | 3.73 % | ||||
| Current Ratio | 5.51 X | ||||
| Book Value Per Share | (0.12) X | ||||
| Cash Flow From Operations | (68.17 M) | ||||
| Earnings Per Share | (0.41) X | ||||
| Market Capitalization | 1.36 B | ||||
| Total Asset | 145.27 M | ||||
| Retained Earnings | (2.09 B) | ||||
| Working Capital | 80.9 M | ||||
| Current Asset | 285.72 M | ||||
| Current Liabilities | 66.91 M | ||||
About Precigen Performance
By examining Precigen's fundamental ratios, stakeholders can obtain critical insights into Precigen's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Precigen is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 19.00 | 18.05 | |
| Return On Tangible Assets | (1.19) | (1.13) | |
| Return On Capital Employed | (1.25) | (1.19) | |
| Return On Assets | (1.00) | (0.95) | |
| Return On Equity | (3.77) | (3.58) |
Things to note about Precigen performance evaluation
Checking the ongoing alerts about Precigen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Precigen help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Precigen is way too risky over 90 days horizon | |
| Precigen appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 3.92 M. Net Loss for the year was (126.23 M) with loss before overhead, payroll, taxes, and interest of (52.67 M). | |
| Precigen currently holds about 115.3 M in cash with (68.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.55. | |
| Roughly 63.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Zenas BioPharma Hits New 52-Week High Whats Next |
- Analyzing Precigen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Precigen's stock is overvalued or undervalued compared to its peers.
- Examining Precigen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Precigen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Precigen's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Precigen's stock. These opinions can provide insight into Precigen's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Precigen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precigen. If investors know Precigen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precigen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.41) | Revenue Per Share | Quarterly Revenue Growth 0.194 | Return On Assets | Return On Equity |
The market value of Precigen is measured differently than its book value, which is the value of Precigen that is recorded on the company's balance sheet. Investors also form their own opinion of Precigen's value that differs from its market value or its book value, called intrinsic value, which is Precigen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precigen's market value can be influenced by many factors that don't directly affect Precigen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precigen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Precigen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precigen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.